Market Overview:
The global medical maggots market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic wounds, rising demand for minimally invasive surgeries, and growing awareness about the benefits of medical maggots therapy. Based on type, the global medical maggots market can be segmented into drugs, medicated bandages, and other products. The drugs segment is expected to account for the largest share of the market in 2018 owing to its high efficacy in treating chronic wounds. By application, hospitals are expected to account for the largest share of the global medical maggots market in 2018 followed by clinics and ambulatory surgical centers (ASCs). Geographically, North America is estimated to dominate the global medical maggots market in 2018 followed by Europe and Asia Pacific.
Product Definition:
Medical maggots are a species of fly larva that feed on necrotic tissue, and are used in wound care to clean and debride wounds. They can be purchased from medical supply stores, or collected from nature.
Drugs:
Drugs are substances that help in curing or preventing diseases. They can be natural or synthetic in nature. The most commonly used drugs include antibiotics, painkillers, anti-inflammatory drugs and anesthetics among many others. Pharmaceutical companies develop these products by extensive research and testing to cater to unmet medical needs of the population which includes new drug development as well as discovery of previously untapped therapeutic applications for existing pharmaceuticals.
Medicated Bandage:
Medicated bandage is a type of dressing used to prevent direct contact injuries from occurring on the skin. It helps in protecting the injury and healing it at the same time. Medicated bandages are also useful for treating pressure ulcers, second-degree burns, and other wounds.
Application Insights:
Based on the application, the global medical maggots market is segmented into hospitals, clinics and ambulatory surgical centers, and other. Hospitals held the largest share of over 70.0% in 2017 owing to high usage of medical maggot therapy for various conditions including deep vein thrombosis (DVT) & pulmonary embolism (PE). Clinics are expected to be fastest growing segment with a CAGR of XX% during the forecast period due to increasing utilization as an alternative treatment for chronic wounds or incisions caused due to accidents or surgeries.
Ambulatory surgical centers are anticipated ¢â‚¬Å“to witness significant growth during the forecast period owing to rising awareness about availability of advanced treatments such as surgery by video-assisted techniques that do not require hospitalization which reduces overall healthcare costs associated with it.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. High prevalence of chronic and infectious diseases, rapid healthcare infrastructure development, and favorable reimbursement policies are some factors contributing to the growth of this regional market.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing awareness about advanced treatment options for maggot therapy among patients, physicians, and other stakeholders in various countries such as India China Japan Australia New Zealand Singapore South Korea Thailand Philippines Vietnam Indonesia Malaysia Maldives Pakistan Sri Lanka Bangladesh Hong Kong China Macau India Taiwan Province Of China ‘The Maggot Therapy’ has been proved effective for healing wounds quickly by treating many war injuries including bullet wound without causing any infection or pain which would otherwise occur after conventional treatments such as sutures or staples etc.
Growth Factors:
- Increasing incidence of chronic wounds: The increasing incidence of chronic wounds is one of the key growth drivers for the medical maggots market. According to a study by the National Institute of Health, around 6.5 million people in the U.S suffer from chronic wounds, which account for more than billion in annual healthcare costs. This number is expected to increase in the coming years due to rising geriatric population and increasing prevalence of lifestyle-associated diseases such as obesity and diabetes.
- Rising demand for minimally invasive procedures: The growing demand for minimally invasive procedures is another major growth driver for medical maggots market. Minimally invasive procedures are less traumatic and result in shorter hospital stays as compared to traditional surgery techniques, thus resulting in lower overall treatment costs. Maggot therapy is a minimally invasive procedure that uses live maggots to cleanse and debride necrotic tissue from a wound bed, thereby promoting wound healing process..
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Maggots Market Research Report
By Type
Drugs, Medicated Bandage, Other
By Application
Hospitals, Clinics, Ambulatory Surgical Centers, Other
By Companies
BioMonde, Monarch Labs, Reliance Medical Group, Mega Pharma (Pvt) Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
132
Number of Tables & Figures
93
Customization Available
Yes, the report can be customized as per your need.
Global Medical Maggots Market Report Segments:
The global Medical Maggots market is segmented on the basis of:
Types
Drugs, Medicated Bandage, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BioMonde
- Monarch Labs
- Reliance Medical Group
- Mega Pharma (Pvt) Ltd
Highlights of The Medical Maggots Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drugs
- Medicated Bandage
- Other
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Maggots Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical maggots are larvae of the fly Drosophila melanogaster. They are used in medical procedures to clean and remove dead tissue from wounds.
Some of the key players operating in the medical maggots market are BioMonde, Monarch Labs, Reliance Medical Group, Mega Pharma (Pvt) Ltd.
The medical maggots market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Maggots Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Medical Maggots Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Medical Maggots Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Medical Maggots Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Medical Maggots Market Size & Forecast, 2020-2028
4.5.1 Medical Maggots Market Size and Y-o-Y Growth
4.5.2 Medical Maggots Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Drugs
5.2.2 Medicated Bandage
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical Maggots Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical Maggots Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Drugs
9.6.2 Medicated Bandage
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Drugs
10.6.2 Medicated Bandage
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Drugs
11.6.2 Medicated Bandage
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Drugs
12.6.2 Medicated Bandage
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Drugs
13.6.2 Medicated Bandage
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical Maggots Market: Competitive Dashboard
14.2 Global Medical Maggots Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BioMonde
14.3.2 Monarch Labs
14.3.3 Reliance Medical Group
14.3.4 Mega Pharma (Pvt) Ltd
